ClinicalTrials.gg
Not yet recruitingNCT07807397Updated Sep 8, 2026

Oral Hygiene Assistance Training Program

A Phase 4 interventional study of Stannous Fluoride Toothpaste (SnF) and sodium fluoride 5000 ppm in Elderly, Periodontal Disease and Gingivitis, sponsored by Colgate Palmolive. Not yet recruiting. Open to participants aged 60 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-09-08.

Primary conditionGingivitisRegistry: Periodontal DiseasesReclassifiedWhy we changed it
Registry
Periodontal Diseases — the first condition term the registry derived for this study.
ClinicalTrials.gg
Gingivitis
Why
  1. The study's listed conditions name Gingivitis, a narrower term within Periodontal Diseases.
Confidence
High: the new condition is named in the study's own listed conditions. Of 351 hand-checked studies reclassified this way, 68% were exactly right and 84% in the right disease family; the registry's first term was right for 5% (measured 2026-10-21). How we classify →
Wrong?
Tell us the study's main condition →

Sponsored by Colgate Palmolive · Phase 4, Interventional, and Treatment

Phase
Phase 4
Study type
Interventional
Enrollment
500
Allocation
Non-randomized
Ages
60 Years and older
Sex
All
01

Study summary

This is an oral health study with a nursing home staff training program and product intervention.

Read the detailed description

This study will be completed in partnership with the Missouri Department of Health and Senior Services, McCoy Samples Mattingly Dental Clinic, and Feno, inc. The study involves a nursing home staff training program, product intervention, and oral health outcomes.

02

Conditions studied

  • Elderly
  • Periodontal Disease
  • Gingivitis
  • Caries,Dental

Browse trials for

Keywords

  • Caries
  • Gingivitis
  • Nursing Home
  • Pneumonia
  • Periodontal Disease
  • Behavior Change
  • toothbrushing
  • mouthwash
  • toothpaste
  • Elderly
03

In context

Gingivitis Reclassified

631 studies on the registry are indexed under Gingivitis; 107 are open to participants now.

This study's planned enrollment of 500 is above the median of 66 across 507 interventional studies indexed under Gingivitis.

Browse Gingivitis studies →

Lead sponsor

Colgate Palmolive is the lead sponsor of 119 studies on the registry; 13 are open to participants now.

Of its 36 completed or terminated interventional studies of FDA-regulated products, 2 (6%) have results posted.

Compared within Gingivitis, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Periodontal Diseases. The counts are of registry records indexed under each term, refreshed daily. How we classify →

04

Who can participate

Ages eligible
60 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Signed Form to receive on-site dental care and grant access to their medical and dental records, and Consent for information collection, consultation, and disease control oral healthcare treatment
  • Male and female subjects aged 60 years or older.
  • A resident of one of the nursing home sites.
  • ASA physical classification status of II, III, or IV (excluding high frailty scores)
  • Frailty assessment of low or moderate

Exclusion criteria

Exclusion Criteria:

  • Tumor(s) of the soft or hard tissues of the oral cavity.
  • History of allergies to oral care/personal care consumer products or their ingredients.
  • ASA category V patients
  • High frailty assessment
  • Resident deemed behaviorally difficult in interview or initial assessment
  • Endentulous
  • Fractured teeth and/or root tips present
  • Oral lesions
  • Grossly mobile teeth for Cohort B
  • Temporary crowns for Cohort B
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Phase 4
Primary purpose
Treatment
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
500 participants (estimated)

Study arms

  • Experimental
    Cohort A

    Subjects in this arm of the trial will use a manual or power toothbrush, OTC and/or Rx toothpaste, and OTC and/or Rx mouthwash.

    Drug: Stannous Fluoride Toothpaste (SnF) · Drug: sodium fluoride 5000 ppm · Drug: cetylpyridinium chloride (0.075%) and zinc alcohol free mouthwash · Drug: sodium fluoride Mouthwash · Drug: Chlorhexidine 0,12%

  • Experimental
    Cohort B

    Subjects in this arm of the trial will use a smart toothbrush, a cosmetic toothpaste, and an OTC and/or Rx mouthwash.

    Drug: sodium fluoride Mouthwash · Drug: Chlorhexidine 0,12% · Device: connected toothbrush · Other: xylitol toothpaste

Interventions

  • Cohort A will use a stannous fluoride toothpaste

  • Drugsodium fluoride 5000 ppm

    Cohort A will have the option of using a sodium fluoride 5000 ppm toothpaste if prescribed by the dentist.

  • Drugcetylpyridinium chloride (0.075%) and zinc alcohol free mouthwash

    Cohort A will use an antiplaque/antigingivitis mouthwash

  • Cohort A and Cohort B may use the sodium fluoride OTC mouthwash

  • DrugChlorhexidine 0,12%

    Cohort A and Cohort B may use a 0.12% chlorhexidine alcohol free mouthwash

  • Deviceconnected toothbrush

    Cohort B will use a u-shaped connected "smart" toothbrush

  • Otherxylitol toothpaste

    Cohort B will use a xylitol toothpaste

06

What researchers measure

Primary outcomes

  1. Incidence of pneumonia

    Incidence of pneumonia acquired during the study

    Time frame: 1 year

Secondary outcomes

  1. Diabetes status

    Time frame: every 3 months for 1 year

  2. HbA1c value

    Time frame: Every 3 months for 1 year

  3. Oral Health History

    Significant history of oral health

    Time frame: Baseline

  4. Oral Health Status

    This includes plaque, calculus, stain, visible inflammation, and oral hygiene status

    Time frame: Monthly for one year

  5. Level of adherence to oral hygiene regimen

    This is a measure of how adherent the nursing home staff was in completing each instance of oral hygiene regimens for the subjects.

    Time frame: Monthly for 1 year

  6. Satisfaction with program

    This will be captured via surveys for the subjects, facility staff, and facility leadership at different times throughout the study.

    Time frame: 1 year

07

Study locations

No study locations are listed for this record.

08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 8, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07807397
Lead sponsor
Colgate Palmolive
Collaborators
McCoy Samples Mattingly Dental Clinic, FENO.Co
Responsible party
Sponsor
First posted
Sep 8, 2026
Start date
Sep 20, 2026 (estimated)
Primary completion
Sep 2027 (estimated)
Completion
Sep 2027 (estimated)
Last update
Sep 8, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
Yes
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Studies of the drug tested here: Tin Fluorides

Start the discussion